RHB-105
RHB-105-02
Phase 3 small_molecule completed
Quick answer
RHB-105 for Helicobacter Pylori Infection is a Phase 3 program (small_molecule) at RedHill Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RedHill Biopharma
- Indication
- Helicobacter Pylori Infection
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed